Shelter Pharma share price rallied over 12% in intraday trade on May 11, 2026, after the company launched ‘FOLIMAN’ Folic Acid Tablets. The Vitamin B-9 supplement has been introduced initially in the international market. The company said the launch supports its nutraceutical expansion strategy and may create additional business growth opportunities.